中文名稱

阿扎尼地平（25毫克）

英文名字

Azelnidipine

供應商

Alomone

產品貨號

ALO-A-135-25

產品報價

￥已停產

產品說明書

點擊查看

購買方式

銀行轉賬、電匯、支票、現金，在線支付寶及網銀支付，或直接與我們電話聯系400-6800-868

產品新聞

背景資料

An antagonist of both CaV1 (all subtypes) and CaV3 (α1G and α1H subtypes), azelnidipine (AZL) is a DHP derivate known to target CaVs with an IC50 of 3 nM. Its long-lasting interaction at multiple binding sites of L-type Ca2+ channels renders it resistant to S(-)-Bay K 8644 (CaV1 channel agonist) activating effects, otherwise shown to counteract nifedipine-induced inhibition; AZL thus confers significantly prolonged cardioactive time. Its reduced side effects and improved cardiovagal baroreflex sensitivity (BRS) when clinically administered make ALZ's therapeutic benefits superior to that of the potent antihypertensive,amlodipine. Additionally, ALZ possesses hydragogue, heart-protective, kidney-protective, and anti-arteriosclerosis capabilities.

產品描述

A Potent Blocker of L-type CaV Channels

產品形式

Both L-type (CaV1) and T-type (CaV3) voltage gated Ca2+ channels are large (~0.5 MDa), transmembrane proteins which control the cellular influx of Ca2+ in response to electrical stimulus; while CaV1s require a strong depolarization (~+40 mV) to perform, a much weaker pulse (~-40 mV) is sufficient to activate CaV3s. Ca2+ channel blockers (CCBs) are a diverse class of pharmaceutical agents, usually targeting L-type channels, of which dihydropyridines (DHPs) constitute a major subgroup. Inhibitors of Ca2+-mediated smooth muscle contractions, CCBs produce vasodilation, thus therapeutically managing hypertension and coronary heart disease.

保存建議

艾美捷為您提供的Alonmone Labs原裝進口的Azelnidipine (25 mg)產品可室溫運輸，建議您在收到產品后將其置于合適的溫度下保存。

其他

Alomone成立于1989年,已經成為全世界科學家信賴的最全面的離子通道研究工具供應商。產品覆蓋離子通道、G蛋白耦聯受體和神經信號研究所需的一抗、小分子、蛋白質和多肽等。所有Alomone產品均進行了生物實驗驗證，以凍干粉形式提供，可確保產品生物活性和保質期。Alomone可提供多種包裝規格，靈活方便。作為Alomone Labs在中國的區域總代理，艾美捷科技有限公司將為中國客戶提供最全面的Alomone Labs產品以及客戶訂制化服務。

注意

該頁面的中文產品信息的翻譯，僅供參考。準確的產品信息請以廠家的英文說明書為準。下單前，請瀏覽說明書確認。

分享到：